Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Timoptic ocudose cost?According to recent market data tezspire tezepelumab had a 7 1 share of paid biologic prescriptions trx in the u's from may 2023 to april 2024 recent data from statista shows tezspire's market?Generic apalutamide availability?Xarelto loss of exclusivity date?Bempedoic acid patent expiration date?
See the DrugPatentWatch profile for Keytruda
Keytruda (pembrolizumab) received its first FDA approval in 2014. [1]
That 2014 date refers to Keytruda’s initial FDA approval. After that, the FDA approved additional indications in later years as new clinical results supported them. [1]
[1] https://www.drugpatentwatch.com/portfolio/keytruda-pembrolizumab/
Other Questions About Keytruda :